RECRUITING

Pervasive Sensing and AI in Intelligent ICU

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Important information related to the visual assessment of patients, such as facial expressions, head and extremity movements, posture, and mobility are captured sporadically by overburdened nurses, or are not captured at all. Consequently, these important visual cues, although associated with critical indices such as physical functioning, pain, delirious state, and impending clinical deterioration, often cannot be incorporated into clinical status. The overall objectives of this project are to sense, quantify, and communicate patients' clinical conditions in an autonomous and precise manner, and develop a pervasive intelligent sensing system that combines deep learning algorithms with continuous data from inertial, color, and depth image sensors for autonomous visual assessment of critically ill patients. The central hypothesis is that deep learning models will be superior to existing acuity clinical scores by predicting acuity in a dynamic, precise, and interpretable manner, using autonomous assessment of pain, emotional distress, and physical function, together with clinical and physiologic data.

Official Title

Pervasive Sensing and Artificial Intelligence in Intelligent ICU Subtitles: -Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making -ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention

Quick Facts

Study Start:2021-05-24
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05127265

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * aged 18 or older
  2. * admitted to UF Health Shands Gainesville ICU ward
  3. * expected to remain in ICU ward for at least 24 hours at time of screening
  1. * under the age of 18
  2. * on any contact/isolation precautions
  3. * expected to transfer or discharge from the ICU in 24 hours or less
  4. * unable to provide self-consent or has no available proxy/LAR

Contacts and Locations

Study Contact

Andrea Davidson, BS
CONTACT
352-294-8723
adavidson@ufl.edu
Brooke Armfield, PhD
CONTACT
352-294-8723
barmfield@ufl.edu

Principal Investigator

Azra Bihorac, MD, MS
PRINCIPAL_INVESTIGATOR
University of Florida

Study Locations (Sites)

University of Florida Health Shands Hospital
Gainesville, Florida, 32610
United States

Collaborators and Investigators

Sponsor: University of Florida

  • Azra Bihorac, MD, MS, PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-05-24
Study Completion Date2024-12

Study Record Updates

Study Start Date2021-05-24
Study Completion Date2024-12

Terms related to this study

Keywords Provided by Researchers

  • Critical Illness
  • Pain
  • Delirium
  • Confusion
  • Patient Acuity
  • ICU
  • Acute Illness

Additional Relevant MeSH Terms

  • Critical Illness
  • Pain
  • Delirium
  • Confusion